Hi Tech Pharmacal Co. Earnings: Everything You Must Know Now
Hi Tech Pharmacal Co. Inc. (NASDAQ:HITK) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company.
Hi Tech Pharmacal Co. Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 33.33% to $0.44 in the quarter versus EPS of $0.66 in the year-earlier quarter.
Revenue: Decreased 2.96% to $50.5 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Hi Tech Pharmacal Co. Inc. reported adjusted EPS income of $0.44 per share. By that measure, the company missed the mean analyst estimate of $0.50. It missed the average revenue estimate of $57.95 million.
Key Stats (on next page)…
Revenue decreased 13.63% from $58.47 million in the previous quarter. EPS were the same at $0.44 as the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.61 to a profit $0.59. For the current year, the average estimate has moved down from a profit of $2.63 to a profit of $2.22 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)